Acomplia Rimonabant Weight loss Oral drug
Rimonabant Acomplia is a wonder diet pill manufactured by Sanofi Aventis for weight loss treatment. Rimonabant Acomplia Zimulti has been approved by European Union in June 2006 and now has become the most popular treatment for weight loss in obese people. Rimonabant Acomplia is also known as magic drug as it helps for smoking cessation as well as heart diseases.
Erectile Dysfunction - What Is Erectile Dysfunction?
Erectile dysfunction is a particularly difficult problem to treat. Not because the symptoms of the problem cant be treated but because the person who suffers from it may feel too embarrassed to seek treatment. There are many physical and psychological reasons why a person might be suffering from this problem and a few questions to the doctor could begin to uncover the source of the problem.
Erectile Dysfunction And Levitra: Satisfied Users Speak Out
From time to time we ask some of our customers how we?re doing, and what they think of the products we sell In a survey of some of our repeat customers who purchase Levitra and other products, we asked the following questions:
1
Kamagra: Doing Away with Erectile Dysfunction
Are you a man that is dealing with an erectile dysfunction and you don?t know what to do about it? If you are suffering from any number of erectile issues you don?t have to keep it to yourself, instead you need to talk to your doctor. ED doesn?t have to be the end of your sex life or something that damages your self esteem. Kamagra is a drug that your doctor can prescribe to you that will treat your impotence or chronic erectile issues. Many men are able to reverse their problems and begin leading a happy and healthy sex life again when they take this drug.
Erectile Dysfunction and Kamagra
Men suffer from erectile dysfunction although there is not a man out there who likes to think about it. It is just a natural occurrence that can happen due to psychological or physical reasons and men should realize there are drugs available to help them with their erection problems. One of these drugs is kamagra. Kamagra is a phosphodiesterase inhibitor and it works simply because it allows a man to get an erection and keep it throughout the act of lovemaking. There are many other erectile dysfunction drugs on the market as well like Viagra, penegra, caverta, and more. There are generic versions of name brand drugs that cost significantly less than the other drugs and allow men to affordably handle their erection problems.
Erectile dysfunction sufferers buy Viagra online in growing numbers
About half of men over the age of 40 have difficulties getting or keeping an erection. This problem, referred to in medical circles as Erectile Dysfunction or impotence, keeps millions of men from enjoying the sex life they once had. Sex can be one of the most fulfilling activities of one?s life, so erectile dysfunction can be devastating. This lack of enjoyment is often accompanied by embarrassment and the feeling of inferiority. Previous generations have had a hard or impossible time overcoming erectile dysfunction. Recent technology has allowed us to treat erectile dysfunction with proficiency.
Get treatment for Impotence with Cialis Tadalafil
Cialis (Tadalafil) Male impotence treatment
Rimonabant (Acomplia, Zimulti, Slimona, Obitone)
Rimonabant (Acomplia, Zimulti, Slimona, Obitone)
Mexican Pharmacies Online | Foreign Online Pharmacies | Buy Lipitor Online
Among all foreign online pharmacies Canadian internet pharmacy offers complete online prescription pharmacy products. You have a valid right to buy online drugs from this part of the world. The list of various medicines describing the symbolic use and precautions is available. Here we recommend products, if you want us to , or if you already have been suggested by a doctor or specialist we comply and guarantee our adherence in all specific orders. Our online store serves in both disciplines either generic or branded.
Lipitor may soon lose its market share to generics
Pfizer?s blockbuster medicine Lipitor patent soon expires. The question now is can Pfizer's big brands stand up to generic competition while the US markets seeks cheaper alternatives? Lipitor has already been removed from a drug managers list of preferred drugs said a report in Financial Times in London.
Viagra: Uses Other Than Treatment of Erectile Dysfunction
The little blue pill is known to many as the main treatment for erectile dysfunction, but does the miracle pill have other uses that we are just learning about Sildenafil is the technical name for the drug is similar to other drugs on the market like cialis and levitra
Levitra An Outstanding Erectile dysfunction treatment
About Levitra
Generic Cialis Tadalafil - Impotence Treatments
Generic Cialis is reasonable and easy on the pocket supplement to the original treatment for erectile dysfunction which is known as Generic Tadalafil (cialis). Generic Cialis contains the same active ingredient Tadalafil which is being used in the Branded drug. Generic version of Generic Tadalafil (cialis) works as effectively as Generic Tadalafil (cialis) or even quicker with much better results. Effect of the drug is much longer than the other pills which are available in the market with a much higher success ratio.
Generic Cialis Tadalafil - Impotence Treatments
Generic Cialis is reasonable and easy on the pocket supplement to the original treatment for erectile dysfunction which is known as Generic Tadalafil (cialis). Generic Cialis contains the same active ingredient Tadalafil which is being used in the Branded drug. Generic version of Generic Tadalafil (cialis) works as effectively as Generic Tadalafil (cialis) or even quicker with much better results. Effect of the drug is much longer than the other pills which are available in the market with a much higher success ratio.
Viagra Sildenafil Citrate Erectile Dysfunction Drug Information
Viagra or generic viagra sildenafil citrate is the most popular drug in the history of the pharmaceutical industry, no drug has ever received such rave review and success as it did. There is hardly any person today who does not know what the drug is meant for. It was approved on March 27, 1998 by the U.S. Food and Drug Administration, after which it received widespread popularity as it proved to be an effective drug for the treatment of sexual health problem in men called erectile dysfunction (ED) or impotence.
|
 |
 |
Torcetrapib and Rimonabant-Acomplia: Promising Next-Generation "Good" Cholesterol Raising Drugs
Generics24.com - Online Pharmacy |
Generic Viagra |
Kamagra Oral Jelly |
Generic Cialis |
Generic Levitra |
ED Trial Pack |
Generic Propecia |
Generic Proscar |
Generic Avodart |
Generic Acomplia |
Generic Xenical |
Generic Zyban |
Generic Imitrex
New York (PRWEB) November 17, 2006 -- Based on compelling evidence that raising high-density lipoprotein cholesterol levels (HDL-C, also known as "good" cholesterol) helps halt atherosclerosis, pharmaceutical companies are racing to produce the next generation of medications to replace the ineffectual ones currently on the market. Niacin, the current drug of choice, increases HDL-C by only 15% to 35%, and then only at daily doses three grams or higher, increasing the chance for unpleasant side effects.
Today at the 33rd annual VEITHsymposium™, Dr. Russell H. Sampson, former Associate Professor of Surgery at the Albert Einstein College of Medicine (Bronx, NY) and current President of Mote Vascular Foundation, Inc. (Sarasota, FL), provided a comprehensive overview of the current state of good cholesterol-raising drugs, including two of the more promising ones, Torcetrapib and Rimonabant-Acomplia.
Torcetrapib (discovered and developed by Pfizer), is a cholesteryl ester transfer protein (CETP) inhibitor. In theory, by blocking CETP it should be possible to improve the ratio of HDL-C to low-density lipoprotein cholesterol (LDL-C, also known as "bad" cholesterol), thus slowing the development and progression of atherosclerosis. Early Phase 2 data published in April 2004 showed that inhibiting CETP with torcetrapib at 120 mg per day produced significant increases in HDL-C when given alone (46%), as well as in combination with Lipitor (61%). When the dosage of torcetrapib was increased to 240 mg per day, HDL-C increased by over 100%. However, patients taking 60 mg of torcetrapib with Lipitor also experienced an increase in systolic blood pressure, a drawback which may outweigh the benefit of raised HDL-C. It is currently estimated
that Torcetrapib will be in the U.S. market in 2008.
Rimonabant-Acomplia (discovered and developed by Sanofi-Aventis) is a CB1 endocannabinoid receptor antagonist. CB1 blockers act on the endocannabinoid system, a system controlling energy and nicotine dependence, reducing the overstimulation thought to lead to obesity and nicotine addiction. In a recent study, 1,036 overweight or obese patients with blood lipid disorders were randomly placed in one of three groups (placebo vs. 5 mg or 20 mg per day of Rimonabant-Acomplia). After one year of treatment, patients receiving 20 mg per day of Rimonabant-Acomplia lost an average of 20 pounds, compared to only 5 pounds for patients on placebo. Further comparisons between the placebo and 20 mg per day Rimonabant-Acomplia group showed that the latter patients enjoyed significant improvements in waist circumference and HDL-C and triglyceride levels, all important factors in maintaining heart health. The drug was said to be well tolerated, with only mild and transient side effects like dizziness and gastrointestinal distress. The drug is currently only approved for sale in Europe, with a date for U.S. availability still uncertain.
Dr. Samson said, "We are about to see a whole new generation of medications to help control atherosclerosis the leading cause of death and disability in the USA and most industrial nations. Current medications may halt or slow down progression, however, it is predicted that these medications may revolutionize treatment by actually reversing this disease that is responsible for heart attack, stroke, and amputations. I am extremely excited by the prospect."
About VEITHsymposium™
Now entering its fourth decade, VEITHsymposium™ provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features 300 rapid-fire presentations from the world's most renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques.
###
This press release has been reprinted from PRWEB per the terms and conditions of the copyright notice.
|
